New Institute to Enhance Treatment of HIV/AIDS Patients in Sub-Saharan Africa

Article excerpt

KAMPALA, UGANDA

The Infectious Diseases Institute (IDI), a new medical facility providing state-of-the-art training and treatment of HIV/AIDS and other infectious diseases opened its doors on the grounds of the Makerere University. The institute, one of the largest centers of its kind in East Africa, has the capacity to treat up to 300 HIV/AIDS patients daily and will be a major center for training medical professionals in advanced HIV/AIDS management techniques.

The opening of the IDI is the result of a unique, public-private partnership between a number of organizations committed to working across borders to advance HIV/AIDS, malaria and tuberculosis prevention, diagnosis and care.

The partnership includes Pfizer Inc, a global pharmaceutical company, Makerere University, Pangaea Global AIDS Foundation, the Academic Alliance Foundation for AIDS Care and Prevention in Africa and the Infectious Diseases Society of America.

Pfizer Inc and the Pfizer Foundation have contributed more than $15 million to support construction of the building, equipping and staffing programs at the new facility where training, operational research and patient care will be delivered under the same roof. …